|
Name |
4''-Deoxyterphenyllin
|
Molecular Formula | C20H18O4 | |
IUPAC Name* |
2-(4-hydroxyphenyl)-3,6-dimethoxy-5-phenylphenol
|
|
SMILES |
COC1=C(C(=C(C(=C1)C2=CC=CC=C2)OC)O)C3=CC=C(C=C3)O
|
|
InChI |
InChI=1S/C20H18O4/c1-23-17-12-16(13-6-4-3-5-7-13)20(24-2)19(22)18(17)14-8-10-15(21)11-9-14/h3-12,21-22H,1-2H3
|
|
InChIKey |
LVUGIAPKIURDNR-UHFFFAOYSA-N
|
|
Synonyms |
4''-Deoxyterphenyllin; CHEBI:67535; P8MM2CV9BY; 59904-04-0; CHEMBL1951870; (1,1':4',1''-Terphenyl)-2',4-diol, 3',6'-dimethoxy-; 4-Deoxyterphenyllin; 4'-Deoxyterphenyllin; UNII-P8MM2CV9BY; 4''''-Deoxyterphenyllin; DTXSID201236995; BDBM50457918; Q27136004; 3',6'-dimethoxy-1,1':4',1''-terphenyl-2',4-diol; 3',6'-Dimethoxy[1,1':4',1''-terphenyl]-2',4-diol
|
|
CAS | 59904-04-0 | |
PubChem CID | 57345621 | |
ChEMBL ID | CHEMBL1951870 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 322.4 | ALogp: | 4.4 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 58.9 | Aromatic Rings: | 3 |
Heavy Atoms: | 24 | QED Weighted: | 0.713 |
Caco-2 Permeability: | -4.831 | MDCK Permeability: | 0.00001830 |
Pgp-inhibitor: | 0.028 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.036 |
30% Bioavailability (F30%): | 0.024 |
Blood-Brain-Barrier Penetration (BBB): | 0.064 | Plasma Protein Binding (PPB): | 99.68% |
Volume Distribution (VD): | 0.624 | Fu: | 1.01% |
CYP1A2-inhibitor: | 0.954 | CYP1A2-substrate: | 0.846 |
CYP2C19-inhibitor: | 0.961 | CYP2C19-substrate: | 0.072 |
CYP2C9-inhibitor: | 0.806 | CYP2C9-substrate: | 0.931 |
CYP2D6-inhibitor: | 0.487 | CYP2D6-substrate: | 0.914 |
CYP3A4-inhibitor: | 0.608 | CYP3A4-substrate: | 0.474 |
Clearance (CL): | 5.995 | Half-life (T1/2): | 0.606 |
hERG Blockers: | 0.186 | Human Hepatotoxicity (H-HT): | 0.036 |
Drug-inuced Liver Injury (DILI): | 0.882 | AMES Toxicity: | 0.145 |
Rat Oral Acute Toxicity: | 0.113 | Maximum Recommended Daily Dose: | 0.026 |
Skin Sensitization: | 0.579 | Carcinogencity: | 0.172 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.557 |
Respiratory Toxicity: | 0.121 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005037 | 0.805 | D0L6DA | 0.383 | ||||
ENC000826 | 0.747 | D0H6TP | 0.383 | ||||
ENC002759 | 0.747 | D0Y7EM | 0.373 | ||||
ENC005870 | 0.720 | D0Q9ON | 0.371 | ||||
ENC005871 | 0.720 | D0R2OA | 0.362 | ||||
ENC005039 | 0.687 | D06TJJ | 0.359 | ||||
ENC002453 | 0.656 | D05UWI | 0.356 | ||||
ENC005869 | 0.640 | D05VLS | 0.354 | ||||
ENC005866 | 0.634 | D0YB1G | 0.351 | ||||
ENC005865 | 0.634 | D09VXM | 0.350 |